Mereo BioPharma Group plc ADR logo

Mereo BioPharma Group plc ADR (MREO)

Market Open
26 Oct, 07:00 PM
NASDAQ (CM) NASDAQ (CM)
$
0. 28
-0
-0.6035%
$
48.39M Market Cap
- P/E Ratio
- Div Yield
264,776 Volume
0 Eps
$ 0.28
Previous Close
Add Transaction
Day Range
0.28 0.29
Year Range
0.2 2.37
Want to track MREO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Mereo BioPharma Group plc ADR Investors

Name Quantity Cost Value Profit ($) Gain (%)
MM
Mike Muhizi SG Americas Securities LLC
12,802 $4,000 $3,548.71 -$451.29 -11.28%
RS
Robert Sterner Rangeley Capital LLC
329,200 $137,177.8 $92,472.28 -$44,705.52 -32.59%
KE
Kathleen Engler Baader Bank Aktiengesellschaft
12,330 $5,137.91 $3,416.64 -$1,721.27 -33.5%
RS
Richard Sproll Tejara Capital Ltd.
2.04M $4.07M $571,524.36 -$3.5M -85.95%
Richard Slavik
Richard Slavik Newbridge Financial Services Group Inc.
18,750 $45,789.3 $5,235 -$40,554.3 -88.57%
SAS
Stephane Astruc/ Salomon Sebban J. Safra Sarasin Holding AG
12,841 $4,081 $3,546.68 -$534.32 -13.09%
Michael Stulic
Michael Stulic Astoria Portfolio Advisors LLC
10,000 $4,167 $2,778 -$1,389 -33.33%
JJB
James J. Burns & Company LLC James J. Burns & Company LLC
95,400 $29,001.6 $26,721.54 -$2,280.06 -7.86%
Darren Tapley
Darren Tapley New England Capital Financial Advisors LLC
300 $225 $83.16 -$141.84 -63.04%
Kelly Christopher
Kelly Christopher Significant Wealth Partners LLC
32,677 $48,218.9 $9,129.95 -$39,088.95 -81.07%